Looker Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Jan 21, 2026
Research Summary
AI-generated summary of this filing
Esperion (ESPR) General Counsel Benjamin Looker Sells 1,689 Shares
What Happened
- Benjamin Looker, General Counsel of Esperion Therapeutics (ESPR), sold 1,689 shares on January 20, 2026 at $2.88 per share for proceeds of $4,868. The filing indicates the sale was an open market or private sale and the shares were disposed to satisfy a tax obligation on vested restricted stock units (RSUs).
Key Details
- Transaction date and price: 2026-01-20, 1,689 shares at $2.88 each.
- Total proceeds: $4,868.
- Reason/footnote: Sale made to satisfy tax withholding on vested RSUs (footnote F1).
- Filing date: 2026-01-21; filing appears timely (no late filing indicated).
- Shares owned after transaction: Not specified in the provided summary of the filing.
Context
- This was a sale to cover tax obligations related to vested RSUs, a common and routine reason for insider sales (tax withholding), and not necessarily a signal of negative views on the company. No options were exercised and no 10b5-1 plan or other special trading arrangement was reported in the provided details.
Insider Transaction Report
Form 4
Looker Benjamin
Chief Legal Officer
Transactions
- Sale
Common Stock
[F1]2026-01-20$2.88/sh−1,689$4,868→ 384,216 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
Signature
/s/ Sheldon L. Koenig, by power of attorney|2026-01-21